Published in Blood Weekly, October 5th, 2006
"Seladin-1 (SELective Alzheimer's Disease INdicator-1) is an antiapoptotic gene, which is downregulated in brain regions affected by Alzheimer's disease (AD). In addition, seladin-1 catalyzes the conversion of desmosterol into cholesterol," scientists writing in the journal Experimental Cell Research report.
According to S. Benvenuti and colleagues at the University of Florence, "Disruption of cholesterol homeostasis in neurons may increase cell susceptibility to toxic agents.
"Because the hippocampus and the subventricular zone, which are affected in AD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.